Lemm JA, OBoyle D 2nd, Liu M, Nower PT, Colonno R, Deshpande MS, Snyder LB, Martin SW, St Laurent DR. Identification of hepatitis C virus NS5A inhibitors. . J Virol. . 2010. 84(1). 482-491. Find at Google Scholar.
Fridell RA, Qiu D, Wang C, Valera L, Gao M. . Resistance analysis of the hepatitis C virus NS5A inhibitor BMS-790052 in an in vitro replicon syste. Antimicrob Agents Chemother. 2010. 54(9). 3641-3650 . Find at Google Scholar.
Fridell RA, Wang C, Sun JH, OBoyle DR 2nd, Nower P, Valera L, Qiu D, Roberts S, Huang X, Kienzle B, . Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5. Hepatology. 2011. 54(6). 1924-1935. Find at Google Scholar.
Gao M, Nettles RE, Belema M, Snyder LB, Nguyen VN, Fridell RA, Serrano-Wu MH, Langley DR, Sun JH, OB. Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect. . Nature . 2010. 465(7294). 96-100. Find at Google Scholar.
Wang C, Huang H, Valera L, Sun JH, OBoyle DR 2nd, Nower PT, Jia L, Qiu D, Huang X, Altaf A, Gao M, F. Hepatitis C virus RNA elimination and development of resistance in replicon cells treated with BMS-7. Antimicrob Agents Chemother . 2012. 56(3). 1350-1358. Find at Google Scholar.
Spreen W, Wilfret D, Bechtel D, Adkinson K, Lou Y, Jones LH. et al. . GSK2336805 HCV NS5A inhibitor demonstrates potent antiviral activity in chronic hepatitis C (CHC) ge. Hepatology. 2011. 54. 400A. Find at Google Scholar.
Karino Y, Toyota J, Ikeda K, Suzuki F, Chayama K, Kawakami Y, Ishikawa H, Watanabe H, Hernandez D, Y. Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the dire. J Hepatol. . 2013. 58(4). 646-654. Find at Google Scholar.
Peres-da-Silva A, Almeida A, Lampe E. . NS5A inhibitor resistance-associated polymorphism in Brazilian treatment-naive patients infected wit. J. Antimicrob Chemother. 2014. 70(3). 726-730. Find at Google Scholar.